Nicolas Stransky

40.7k total citations · 3 hit papers
27 papers, 3.2k citations indexed

About

Nicolas Stransky is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Nicolas Stransky has authored 27 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Nicolas Stransky's work include Epigenetics and DNA Methylation (6 papers), Fibroblast Growth Factor Research (5 papers) and Lung Cancer Treatments and Mutations (5 papers). Nicolas Stransky is often cited by papers focused on Epigenetics and DNA Methylation (6 papers), Fibroblast Growth Factor Research (5 papers) and Lung Cancer Treatments and Mutations (5 papers). Nicolas Stransky collaborates with scholars based in United States, France and United Kingdom. Nicolas Stransky's co-authors include Christoph Lengauer, Joseph L. Kim, Ethan Cerami, Stefanie S. Schalm, François Radvanyi, Emmanuel Barillot, Philippe Hupé, Jean Paul Thiery, Rami Rahal and Klaus P. Hoeflich and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Nature Genetics.

In The Last Decade

Nicolas Stransky

27 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The landscape of kinase fusions in cancer

2014 657 citations Nicolas Stransky, Ethan Cerami et al. Nature Communications profile →
Targeting cancer with kinase inhibitors

2015 335 citations Rami Rahal, Nicolas Stransky et al. profile →
Accuracy assessment of fusion transcript detection via read-mapping and de novo fusion transcript assembly-based methods

2019 302 citations Brian J. Haas, Alexander Dobin et al. Genome biology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nicolas Stransky United States	17	2.1k	837	832	720	476	27	3.2k
Gulisa Turashvili Canada	29	1.9k 0.9×	1.4k 1.7×	1.2k 1.5×	519 0.7×	392 0.8×	109	3.9k
Peter Riegman Netherlands	31	1.9k 0.9×	766 0.9×	513 0.6×	924 1.3×	505 1.1×	70	3.8k
Harry Boutselakis United Kingdom	4	2.2k 1.1×	1.2k 1.5×	742 0.9×	480 0.7×	456 1.0×	6	3.2k
Peter M. Haverty United States	29	2.4k 1.2×	677 0.8×	846 1.0×	351 0.5×	389 0.8×	38	3.3k
Andrew Strahs United States	20	1.6k 0.8×	750 0.9×	651 0.8×	1.0k 1.4×	307 0.6×	52	2.8k
Sari Ward United Kingdom	5	2.7k 1.3×	1.6k 1.9×	888 1.1×	595 0.8×	591 1.2×	9	3.9k
Joseph A. Holden United States	34	1.6k 0.7×	647 0.8×	1.3k 1.5×	523 0.7×	375 0.8×	108	3.3k
Jesse S. Boehm United States	30	2.9k 1.4×	1.5k 1.8×	1.2k 1.4×	949 1.3×	284 0.6×	51	4.3k
Ronglai Shen United States	17	1.3k 0.6×	1.0k 1.2×	841 1.0×	760 1.1×	174 0.4×	48	2.7k
Nikhil Wagle United States	27	2.6k 1.3×	1.3k 1.5×	1.9k 2.3×	1.1k 1.5×	496 1.0×	102	4.7k

Countries citing papers authored by Nicolas Stransky

Since Specialization

Citations

This map shows the geographic impact of Nicolas Stransky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Stransky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Stransky more than expected).

Fields of papers citing papers by Nicolas Stransky

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolas Stransky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Stransky. The network helps show where Nicolas Stransky may publish in the future.

Co-authorship network of co-authors of Nicolas Stransky

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolas Stransky. A scholar is included among the top collaborators of Nicolas Stransky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolas Stransky. Nicolas Stransky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Ming, Nicolas Stransky, Mark Miglarese, et al.. (2025). Predicting ROS1 and ALK fusions in NSCLC from H&E slides with a two-step vision transformer approach. npj Precision Oncology. 9(1). 266–266. 1 indexed citations

Haas, Brian J., Alexander Dobin, Bo Li, et al.. (2019). Accuracy assessment of fusion transcript detection via read-mapping and de novo fusion transcript assembly-based methods. Genome biology. 20(1). 213–213. 302 indexed citations breakdown →

Dufour, Florent, Hélène Neyret‐Kahn, Clémentine Krucker, et al.. (2019). TYRO3 as a molecular target for growth inhibition and apoptosis induction in bladder cancer. British Journal of Cancer. 120(5). 555–564. 23 indexed citations

Rahal, Rami, Erica N Evans, Wei Hu, et al.. (2016). Abstract 2641: The development of potent, selective RET inhibitors that target both wild-type RET and prospectively identified resistance mutations to multi-kinase inhibitors. Cancer Research. 76(14_Supplement). 2641–2641. 10 indexed citations

Hagel, Margit, Chandra Miduturu, Michael P. Sheets, et al.. (2015). First Selective Small Molecule Inhibitor of FGFR4 for the Treatment of Hepatocellular Carcinomas with an Activated FGFR4 Signaling Pathway. Cancer Discovery. 5(4). 424–437. 247 indexed citations

Stransky, Nicolas, Ethan Cerami, Stefanie S. Schalm, et al.. (2015). Abstract 954: The landscape of kinase fusions in cancer. Cancer Research. 75(15_Supplement). 954–954. 1 indexed citations

Pop, Marius S., Nicolas Stransky, Colin W. Garvie, et al.. (2014). A Small Molecule That Binds and Inhibits the ETV1 Transcription Factor Oncoprotein. Molecular Cancer Therapeutics. 13(6). 1492–1502. 49 indexed citations

Stransky, Nicolas, Ethan Cerami, Stefanie S. Schalm, Joseph L. Kim, & Christoph Lengauer. (2014). The landscape of kinase fusions in cancer. Nature Communications. 5(1). 4846–4846. 657 indexed citations breakdown →

Jones, Siân, Nicolas Stransky, Ethan Cerami, et al.. (2014). Genomic analyses of gynaecologic carcinosarcomas reveal frequent mutations in chromatin remodelling genes. Nature Communications. 5(1). 5006–5006. 123 indexed citations

10.

Shao, Diane D., Aviad Tsherniak, Shuba Gopal, et al.. (2012). ATARiS: Computational quantification of gene suppression phenotypes from multisample RNAi screens. Genome Research. 23(4). 665–678. 78 indexed citations

11.

Dooley, Alison L., Monte M. Winslow, Derek Y. Chiang, et al.. (2011). Nuclear factor I/B is an oncogene in small cell lung cancer. Genes & Development. 25(14). 1470–1475. 126 indexed citations

12.

Dutt, Amit, Alex H. Ramos, Peter S. Hammerman, et al.. (2011). Inhibitor-Sensitive FGFR1 Amplification in Human Non-Small Cell Lung Cancer. PLoS ONE. 6(6). e20351–e20351. 296 indexed citations

13.

Vallot, Céline, Nicolas Stransky, Isabelle Bernard‐Pierrot, et al.. (2010). A Novel Epigenetic Phenotype Associated With the Most Aggressive Pathway of Bladder Tumor Progression. JNCI Journal of the National Cancer Institute. 103(1). 47–60. 59 indexed citations

14.

Peter, Martine, Nicolas Stransky, Jérôme Couturier, et al.. (2010). Frequent genomic structural alterations at HPV insertion sites in cervical carcinoma. The Journal of Pathology. 221(3). 320–330. 80 indexed citations

15.

Bernard‐Pierrot, Isabelle, Claire Dunois-Lardé, Nicolas Stransky, et al.. (2009). Abstract B92: P38 MAPK activation is critical for FGFR3-induced cell transformation in human bladder carcinoma. Molecular Cancer Therapeutics. 8(12_Supplement). B92–B92. 1 indexed citations

16.

Bernard‐Pierrot, Isabelle, Nadège Gruel, Nicolas Stransky, et al.. (2008). Characterization of the Recurrent 8p11-12 Amplicon Identifies PPAPDC1B, a Phosphatase Protein, as a New Therapeutic Target in Breast Cancer. Cancer Research. 68(17). 7165–7175. 73 indexed citations

17.

Stransky, Nicolas, Céline Vallot, Fabien Reyal, et al.. (2006). Regional copy number–independent deregulation of transcription in cancer. Nature Genetics. 38(12). 1386–1396. 178 indexed citations

18.

Rosty, Christophe, Michal Sheffer, Dafna Tsafrir, et al.. (2005). Identification of a proliferation gene cluster associated with HPV E6/E7 expression level and viral DNA load in invasive cervical carcinoma. Oncogene. 24(47). 7094–7104. 115 indexed citations

19.

Fink, Thomas, et al.. (2005). Using mutual information to infer gene-gene interactions from microarray expression series. APS. 1 indexed citations

20.

Cohen‐Boulakia, Sarah, Séverine Lair, Nicolas Stransky, et al.. (2004). Selecting biomedical data sources according to user preferences. Bioinformatics. 20(suppl_1). i86–i93. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact